Acurx Pharmaceuticals Inc (ACXP)
Acurx Pharmaceuticals, Inc. is a late-stage biopharmaceutical company focused on developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections. It develops antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC), inhibiting DNA replication and leading to Gram-positive bacterial cell death.
| Company Name: |
Acurx Pharmaceuticals Inc |
| Website: |
www.acurxpharma.com |
| Sector: |
Drugs & Pharmaceuticals |
| Number of ETFs Holding ACXP: |
3 |
| Total Market Value Held by ETFs: |
$465945 |
| Total Market Capitalization: |
$14.00M |
| % of Market Cap. Held by ETFs: |
3.33% |
|
|
January 24, 2025 • 8:38 PM Eastern
Strong Buy (4.00 out of 4)
100th percentile
|
|
Free ACXP Email Alerts:
